# Launch One Acquisition Corp. (LPAA) Source: https://www.quantisnow.com/company/LPAA Generated: 2026-11-09T12:40:37.582Z - Ticker: LPAA - Exchange: NASDAQ - IPO year: 2024 - SEC CIK: 0002015502 ## Latest LPAA news and filings - 2026-10-20 15:45 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-launch-one-acquisition-6751902) - 2026-08-13 10:27 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-launch-one-acquisition-6679065) - 2026-08-12 21:09 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-launch-one-acquisition-corp-6678548) - 2026-07-13 21:15 UTC [SEC Form 8-K] [Launch One Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/launch-one-acquisition-corp-filed-sec-form-8-k-entry-into-6635702) - 2026-07-07 00:07 UTC [SEC Form 8-K] [Launch One Acquisition Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events](https://www.quantisnow.com/insight/launch-one-acquisition-corp-filed-sec-form-8-k-unregistered-sales-6629265) - 2026-06-25 20:50 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-launch-one-acquisition-corp-6616162) - 2026-06-25 20:45 UTC [SEC Form 8-K] [SEC Form 8-K filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-launch-one-acquisition-corp-6616137) - 2026-06-10 21:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-launch-one-acquisition-corp-6597555) - 2026-06-02 21:20 UTC [SEC Form PRER14A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-launch-one-acquisition-corp-6584978) - 2026-06-02 21:16 UTC [SEC Form 3] [SEC Form 3 filed by new insider Rogers Daniel C](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-rogers-daniel-c-6584943) - 2026-06-02 21:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-launch-one-acquisition-corp-6584938) - 2026-05-18 20:50 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-launch-one-acquisition-corp-6560704) - 2026-05-14 21:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-launch-one-acquisition-corp-6554805) - 2026-03-27 20:20 UTC [SEC Form 10-K] [SEC Form 10-K filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-launch-one-acquisition-corp-6474802) - 2026-03-26 20:06 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6471025) - 2026-03-26 20:05 UTC [SEC Form 8-K] [Launch One Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/launch-one-acquisition-corp-filed-sec-form-8-k-creation-of-6470978) - 2026-02-13 22:39 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-launch-one-acquisition-6393330) - 2026-02-13 14:58 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-launch-one-acquisition-6391405) - 2026-02-13 14:32 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-launch-one-acquisition-6391378) - 2026-02-12 11:57 UTC [SEC Form SCHEDULE 13G filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-launch-one-acquisition-corp-6388114) - 2026-02-11 02:15 UTC [SEC Form SCHEDULE 13G filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-launch-one-acquisition-corp-6385285) - 2026-01-13 17:58 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6347861) - 2026-01-13 14:51 UTC [Public Offering] [Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform](https://www.quantisnow.com/insight/minovia-therapeutics-announces-two-new-us-patents-granted-strengthening-its-6347759) - 2025-11-20 13:30 UTC [Public Offering] [Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition](https://www.quantisnow.com/insight/minovia-therapeutics-mitochondrial-augmentation-technology-to-be-featured-in-presentation-6288184) - 2025-11-13 21:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-launch-one-acquisition-corp-6277898) - 2025-10-15 11:30 UTC [Public Offering] [Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome](https://www.quantisnow.com/insight/minovia-therapeutics-receives-fda-orphan-drug-designation-for-mnv-201-in-6233207) - 2025-09-18 11:30 UTC [Public Offering] [Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome](https://www.quantisnow.com/insight/minovia-therapeutics-receives-fda-fast-track-designation-for-mnv-201-in-6204948) - 2025-08-27 20:05 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6180759) - 2025-08-27 11:15 UTC [Public Offering] [Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers](https://www.quantisnow.com/insight/minovia-therapeutics-announces-350000-grant-from-countdown-for-a-cure-6180031) - 2025-08-14 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-launch-one-acquisition-corp-6166589) - 2025-08-12 21:24 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-launch-one-acquisition-6161434) - 2025-08-12 20:24 UTC [SEC Form SCHEDULE 13G filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-launch-one-acquisition-corp-6160924) - 2025-07-24 20:30 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6131860) - 2025-07-24 12:15 UTC [Public Offering] [Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by Growth](https://www.quantisnow.com/insight/minovia-therapeutics-announces-interim-data-from-phase-2-trial-in-6130931) - 2025-07-01 20:52 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6106362) - 2025-07-01 20:50 UTC [SEC Form 8-K] [Launch One Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/launch-one-acquisition-corp-filed-sec-form-8-k-entry-into-6106346) - 2025-06-30 12:56 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6103058) - 2025-06-30 12:30 UTC [Public Offering] [Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome](https://www.quantisnow.com/insight/minovia-therapeutics-announces-fda-fast-track-and-rare-pediatric-disease-6102980) - 2025-06-25 13:05 UTC [SEC Form 425] [SEC Form 425 filed by Launch One Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-launch-one-acquisition-corp-6098517) - 2025-06-25 12:58 UTC [SEC Form 8-K] [Launch One Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/launch-one-acquisition-corp-filed-sec-form-8-k-regulation-fd-6098456) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LPAA - Earnings history: https://www.quantisnow.com/earnings/LPAA - Dividend history: https://www.quantisnow.com/dividends/LPAA - Insider transactions: https://www.quantisnow.com/insiders/LPAA - Options chain: https://www.quantisnow.com/options/LPAA - SEC 8-K filings only: https://www.quantisnow.com/company/LPAA/8-k - RSS and alerts for LPAA: https://www.quantisnow.com/docs/rss-feeds.md